NL9401006A - Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. - Google Patents

Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. Download PDF

Info

Publication number
NL9401006A
NL9401006A NL9401006A NL9401006A NL9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A
Authority
NL
Netherlands
Prior art keywords
ibuprofen
treatment
salt
pharmaceutical composition
composition according
Prior art date
Application number
NL9401006A
Other languages
English (en)
Dutch (nl)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9401006A publication Critical patent/NL9401006A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL9401006A 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. NL9401006A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
ITMI931324 1993-06-21

Publications (1)

Publication Number Publication Date
NL9401006A true NL9401006A (nl) 1995-01-16

Family

ID=11366435

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9401006A NL9401006A (nl) 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.

Country Status (12)

Country Link
US (1) US5510385A (enExample)
JP (1) JPH0710749A (enExample)
BE (1) BE1007193A5 (enExample)
CA (1) CA2125644C (enExample)
CH (1) CH686866A5 (enExample)
DE (1) DE4420858A1 (enExample)
ES (1) ES2099022B1 (enExample)
FR (1) FR2706891B1 (enExample)
GB (1) GB2279251A (enExample)
IT (1) IT1264855B1 (enExample)
NL (1) NL9401006A (enExample)
SE (1) SE9402156L (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183422A1 (en) * 1994-02-24 1995-08-31 Kiyoshi Mukai Analgesic activity enhancer
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
HUP0401686A3 (en) * 2001-09-28 2008-04-28 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
BR0318201A (pt) 2003-03-21 2006-03-21 Mcneil Ppc Inc regime de dosagem de fármaco antiinflamatório não-esteroidal
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
CA2570649A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
RU2009103000A (ru) * 2006-06-30 2010-08-10 МакНЕЙЛ-ППС, ИНК. (US) Твердые капсулы, наполненные жидкостью, содержащей ибупрофен
BRPI0719021A2 (pt) 2006-11-21 2013-12-17 Mcneil Ppc Inc Suspensões analgésicas de liberação modificada.
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
EP2630955B1 (en) * 2007-08-15 2021-09-22 Johnson & Johnson Consumer Inc. Immediate release and sustained release ibuprofen dosing regimen
US8143314B1 (en) * 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101265178A (zh) * 2008-04-25 2008-09-17 北京阜康仁生物制药科技有限公司 一种右旋布洛芬的氨基酸盐及其药用组合物
MX379054B (es) * 2008-12-04 2025-03-11 Chongxi Yu Composiciones de alta penetracion y sus aplicaciones.
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス，エセ．アー．Ｌａｂｏｒａｔｏｒｉｏ Ｄｅ Ａｐｌｉｃａｃｉｏｎｅｓ Ｆａｒｍａｃｏｄｉｎａｍｉｃａｓ，Ｓ．Ａ． イブプロフェンリシナートの経口投与用の懸濁液
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
ES2519592T3 (es) * 2011-11-17 2014-11-07 Zambon S.P.A. Composiciones sólidas farmacéuticas que contienen sales de ibuprofeno
BR112014019526B8 (pt) 2012-02-07 2022-08-30 Chenango Zero Llc Forma de dosagem de liberação rápida e seu método de produção
HK1212889A1 (zh) 2012-09-18 2016-06-24 Mcneil-Ppc, Inc. 包含低熔点丙酸衍生物颗粒的缓释口服剂型
EP2897584A1 (en) 2012-09-18 2015-07-29 McNeil-PPC, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CN109689030A (zh) 2016-07-19 2019-04-26 强生消费者公司 具有不连续涂覆区域的片剂
EP3541365A1 (en) 2016-11-21 2019-09-25 Just Biotherapeutics, Inc. Aflibercept formulations and uses thereof
WO2019099965A1 (en) 2017-11-20 2019-05-23 Just Biotherapeutics, Inc. Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
BR112020014457A8 (pt) 2018-01-22 2022-07-26 Currahee Holding Company Inc Cápsulas perfuradas
US20210378968A1 (en) 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
DK0424028T3 (da) * 1989-10-17 1996-01-29 Merck & Co Inc S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
EP0505180B1 (en) * 1991-03-22 1996-10-09 Merck & Co. Inc. High-content ibuprofen lysinate pharmaceutical formulation
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations

Also Published As

Publication number Publication date
CA2125644A1 (en) 1994-12-22
SE9402156D0 (sv) 1994-06-20
CA2125644C (en) 2007-06-05
DE4420858A1 (de) 1994-12-22
ES2099022A1 (es) 1997-05-01
ES2099022B1 (es) 1998-01-16
CH686866A5 (it) 1996-07-31
GB2279251A (en) 1995-01-04
US5510385A (en) 1996-04-23
JPH0710749A (ja) 1995-01-13
ITMI931324A1 (it) 1994-12-21
GB9410987D0 (en) 1994-07-20
SE9402156L (sv) 1994-12-22
FR2706891A1 (enExample) 1994-12-30
ITMI931324A0 (it) 1993-06-18
IT1264855B1 (it) 1996-10-17
BE1007193A5 (fr) 1995-04-18
FR2706891B1 (enExample) 1995-10-20

Similar Documents

Publication Publication Date Title
NL9401006A (nl) Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
RU2652345C2 (ru) Кетопрофеновая композиция для местного применения
JPS6327428A (ja) レボドパメチルエステルを有効成分とするパ−キンソン病治療剤
RU2218180C2 (ru) Комбинация анальгетиков
CZ290646B6 (cs) Parenterální farmaceutické kompozice
KR20040063913A (ko) 2-(4-이소부틸페닐)프로피온산의 약학 조성물
Cattaneo et al. Clinical pharmacokinetics of ibuprofen arginine
NL194390C (nl) Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
NL9401005A (nl) Farmaceutische samenstelling met analgetische activiteit.
EP1604658A2 (en) Pharmaceutical composition comprising ibuprofen and prochlorperazine
CN109803953A (zh) 药物制剂及其用途
WO2024166059A1 (en) Compositions comprising n,n-dimethyltryptamine, optionally in combination with n-acylethanolamines and uses thereof
WO2024141626A1 (en) Pharmaceutical formulations of quinolines
KR970011456B1 (ko) d-2-(6-메톡시-2-나프틸)-프로피온산의 광학활성 유도체와 이것을 함유한 약제학적 조성물
KR100567132B1 (ko) 이부프로펜과 아르기닌 함유 고농축 액상 조성물 및연질캡슐제
US4663345A (en) Etodolac for treatment of gout
KR100379155B1 (ko) 새로운 진통제 조성물
KR100523242B1 (ko) 이부프로펜을 함유하는 정제 조성물
WO2024171073A1 (en) Compositions comprising 3,4-methylenedioxymethamphetamine, optionally in combination with n-acylethanolamines, and uses thereof
KR100986531B1 (ko) 액상의 아세클로페낙을 함유하는 캡슐제
EP4661867A1 (en) Compositions comprising n,n-dimethyltryptamine, optionally in combination with n-acylethanolamines and uses thereof
WO2024171075A1 (en) Compositions comprising ibogaine, optionally in combination with n-acylethanolamines, and uses thereof
MXPA03012048A (es) Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
EP2965746B1 (en) An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable